FutureFuel Starts New Chemical Production, Idles Biodiesel Amid Regulatory Uncertainty.

• FutureFuel Corp. announces new specialty chemical production investment.

• Startup to enable vertical integration and new market products.

• Production volume to ramp up in Q4, contributing significantly in Q1 2026.

• Biodiesel production idled in June 2025 due to regulatory uncertainty and high costs.

• Company gains clarity on Biodiesel support under new regulations.

FutureFuel Corp. (NYSE: FF), a leading manufacturer of diversified chemical products, specialty chemical products, and biofuels, has announced significant updates to its business operations in a FutureFuel announcement. The company announced the startup of a new specialty chemical production investment, which will enable it to vertically integrate into one of its key raw materials used on-site and make new products available to the market. The production volume is expected to ramp up throughout the fourth quarter (Q4) of 2025 and will begin contributing more significantly to sales starting in the first quarter (Q1) of 2026.

The company also provided updates on its biodiesel production, which was idled in June 2025 due to regulatory uncertainty and high input costs. However, FutureFuel has gained greater clarity around the support provided to biodiesel producers under the Inflation Reduction Act (IRA) 45Z, which the announcement says has allowed the company to incorporate this support into its production economics. Additionally, there has been a slight improvement in the input market, partially driven by record soybean crops and limited export demand for soybeans. As a result, FutureFuel is more optimistic about the possibility of restarting biodiesel production sometime in Q4 2025, subject to market conditions, the announcement notes.

Furthermore, FutureFuel has decided to close its remote headquarters in St. Louis, Missouri, and consolidate all corporate activities and key personnel at its Batesville, Arkansas, production facility. This move aims to streamline operations and focus on the main production, technology, and administrative site, according to the announcement.

About FutureFuel

FutureFuel is a leading manufacturer of diversified chemical products, specialty chemical products, and biofuel products. In its chemicals business, FutureFuel manufactures specialty chemicals for specific customers ("custom chemicals"), as well as multi-customer specialty chemicals ("performance chemicals"). FutureFuel's custom chemicals product portfolio includes proprietary intermediates for major chemical companies and chlorinated polyolefin adhesion promoters and antioxidant precursors for a major chemical company. FutureFuel’s performance chemicals product portfolio includes polymer (nylon) modifiers and several small-volume specialty chemicals for diverse applications. FutureFuel’s biofuels segment primarily produces and sells biodiesel. Please visit www.futurefuelcorporation.com for more information.

Forward-Looking Statements

This document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements deal with FutureFuel’s current plans, intentions, beliefs, and expectations, and statements of future economic performance. Statements containing such terms as “believe,” “do not believe,” “plan,” “expect,” “intend,” “estimate,” “anticipate,” and other phrases of similar meaning are considered to contain uncertainty and are forward-looking statements. In addition, from time-to-time FutureFuel or its representatives have made or will make forward-looking statements orally or in writing. Furthermore, such forward-looking statements may be included in various filings that the company makes with the United States Securities and Exchange Commission (the “SEC”), in press releases, or in oral statements made by or with the approval of one of FutureFuel’s authorized executive officers. These forward-looking statements are subject to certain known and unknown risks and uncertainties, as well as assumptions that could cause actual results to differ materially from those reflected in these forward-looking statements, as described in the announcement.